Advertisement
U.S. markets closed

Enzon Pharmaceuticals, Inc. (ENZN)

OTC Markets OTCQX - OTC Markets OTCQX Delayed Price. Currency in USD
0.0800+0.0040 (+5.26%)
At close: 03:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.64M
Enterprise Value -40.99M
Trailing P/E 57.58
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)216.94
Price/Book (mrq)2.04
Enterprise Value/Revenue -1.56k
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-20.00%
S&P500 52-Week Change 331.18%
52 Week High 30.2400
52 Week Low 30.0600
50-Day Moving Average 30.1060
200-Day Moving Average 30.1160

Share Statistics

Avg Vol (3 month) 317.55k
Avg Vol (10 day) 315.2k
Shares Outstanding 574.21M
Implied Shares Outstanding 674.21M
Float 830.11M
% Held by Insiders 110.84%
% Held by Institutions 148.58%
Shares Short (May 13, 2016) 4259.38k
Short Ratio (May 13, 2016) 41.71
Short % of Float (May 13, 2016) 40.68%
Short % of Shares Outstanding (May 13, 2016) 40.59%
Shares Short (prior month Apr 15, 2016) 4298.38k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 15, 2019
Ex-Dividend Date 4Sep 30, 2019
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Sep 30, 2024

Profitability

Profit Margin 5,853.85%
Operating Margin (ttm)-4,684.62%

Management Effectiveness

Return on Assets (ttm)-1.61%
Return on Equity (ttm)3.26%

Income Statement

Revenue (ttm)26k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)247k
Diluted EPS (ttm)0.0000
Quarterly Earnings Growth (yoy)-20.90%

Balance Sheet

Total Cash (mrq)46.63M
Total Cash Per Share (mrq)0.63
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)107.24
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)1.35M
Levered Free Cash Flow (ttm)-737.25k